What is the evidence for the efficacy of cariprazine as monotherapy in treating depression?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18186790
Cited by: 0

Abstract

Cariprazine is effective as a monotherapy for depressive episodes in bipolar disorder, but its efficacy as a standalone treatment for unipolar depression remains less established.

Fields of Study & Subjects

Bipolar Disorder and Treatment Neurotransmitter Receptor Influence on Behavior Treatment of Major Depression

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
8 January 2026